Nonsteroidal anti-inflammatory drug-associated dyspepsia: The scale of the problem

American Journal of Medicine

Volumn 110, Issue 1 SUPPL. 1, 2001, Pages S12-S13

  Brun, Johan ^a   Jones, Roger ^b  

^a Södra Hälsocentralen   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG SAFETY; DYSPEPSIA; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; META ANALYSIS; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; ULCER HEALING;

EID: 0035825115     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00629-x     Document Type: Short Survey

References (10)

1. Dyspepsia in England and Scotland
2. Dyspeptic symptoms in the community
3. Challenges in managing dyspepsia in general practice
4. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: Lack of an association in the community
5. Nonsteroidal anti-inflammatory drugs and dyspepsia in the elderly
6. Screening for drug related dyspepsia: An analysis of prescription symmetry
7. Gastrointestinal side-effects of NSAIDs in the community
8. Dyspepsia in the community is linked to smoking and aspirin but not to Helicobacter pylori infection
9. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic non-steroidal anti-inflammatory drug use
10. Dyspepsia in NSAID users: The size of the problem